Main menu

Trial Data & Results

Trial Data & Results

Pfizer believes that it is important for researchers, trial participants, regulators, and others acting in the best interest of patients to have access to clinical trial information to advance medical understanding and progress. It’s also important that this access works in ways that protect patient privacy, preserve regulatory authority and maintain incentives for those who generate data to conduct new research.

Pfizer publicly shares results from our clinical trials, whether the results are neutral, negative or positive. We also share data gathered in clinical trials we sponsor with trial volunteers, researchers, and others.

There are several ways in which we share trial results and data:

1
We submit clinical trial results for publication in peer reviewed journals within 18 months of study completion.

 

2
At the outset of clinical trials, we register those studies on clinicaltrials.gov, the U.S. National Institutes of Health's publicly available clinical trials registry and database. After the completion of those studies, we provide results on clinicaltrials.gov and other registries, in accordance with local regulations and guidelines.
3
We provide access to detailed clinical data in response to legitimate request from researchers and regulators.
4
We post clinical study report (CSR) synopses on our website with a link to the data on clinicaltrials.gov.
5
We provide easy-to-read summaries of trial findings to qualifying clinical trial participants who wish to receive them, and we are piloting a “Blue Button” application to allow U.S. trial volunteers to receive their own data back from the trial in a portable electronic format.
6
We participate in collaborative data-sharing initiatives such as Project Datasphere.

 

Responsible Data Sharing

Pfizer’s practices adhere to the principles for responsible data sharing laid out by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA).